Supreme Court Denies Last Pending Request for Review in Reglan Preemption Case

The U.S. Supreme Court has rejected the third and final request for review of a Pennsylvania state court ruling that would allow individuals to sue generics makers for failing to update warnings on drug labels.

Source:: Drug Industry Daily

Leave a Reply

Your email address will not be published. Required fields are marked *